Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension

Pediatric Pulmonology

Volumn 46, Issue 6, 2011, Pages 617-620

  Gürakan, Berkan ^a   Kayiran, Petek ^a   Öztürk, Nilüfer ^b   Kayiran, Sinan Mahir ^a   Dindar, Aygün ^a  

^a AMERICAN HOSPITAL   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

bronchopulmonary dysplasia; pulmonary hypertension; respiratory syncytial virus

Indexed keywords

DIGOXIN; ILOPROST; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; HIGH FREQUENCY OSCILLATION; HUMAN; HYPOXIA; INFANT; LUNG DYSPLASIA; LUNG FUNCTION TEST; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; THORAX RADIOGRAPHY;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANOXIA; BRONCHOPULMONARY DYSPLASIA; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PIPERAZINES; PURINES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 79955909280     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21415     Document Type: Article

References (17)

1. Parker TA, Abman SH,. The pulmonary circulation in bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 51-61.
2. Dakshinamurti S,. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 2005; 39: 492-503. (Pubitemid 40696319)
3. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH,. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317-325. (Pubitemid 351198454)
4. Tulloh R,. Management and therapeutic options in pediatric pulmonary hypertension. Expert Rev Cardiovasc Ther 2006; 4: 361-374. (Pubitemid 43796994)
5. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP,. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120: 1260-1269. (Pubitemid 350223677)
6. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV,. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-1928. (Pubitemid 46981654)
7. Krishnan U, Krishnan S, Gewitz M,. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol 2008; 29: 1082-1086.
8. Klinger JR,. The nitric oxide/cGMP signaling pathway in pulmonary hypertension. Clin Chest Med 2007; 28: 143-167. (Pubitemid 46343758)
9. Mourani PM, Sontag MK, Ivy DD, Abman SH,. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009; 154: 379-384.
10. Caputo S, Furcolo G, Rabuano R, Basilicata AM, Pilla LM, De Simone A, Pasquariello B, Ciampi Q, Vetrano G, Villari B,. Severe pulmonary arterial hypertension in a very premature baby with bronchopulmonary dysplasia: normalization with long-term sildenafil. J Cardiovasc Med 2010; 11: 704-706.
11. Tissot C, Beghetti M,. Review of inhaled iloprost for the control of pulmonary artery hypertension in children. Vasc Health Risk Manag 2009; 5: 325-331.
12. Budhiraja R, Tuder RM, Hassoun PM,. Endothelial dysfunction in pulmonary hypertension. Circulation 2004; 109: 159-165. (Pubitemid 38114133)
13. Chotigeat U, Jaratwashirakul S,. Inhaled iloprost for severe persistent pulmonary hypertension of the newborn. J Med Assoc Thai 2007; 90: 167-170.
14. Eifinger F, Sreeram N, Mehler K, Huenseler C, Kribs A, Roth B,. Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study. Klin Padiatr 2008; 220: 66-69. (Pubitemid 351518681)
15. Ivy DD, Doran AK, Smith KJ, Mallory GB, Jr., Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH,. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 161-169.
16. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F,. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136: 515-522. (Pubitemid 34252285)
17. Hwang SK, Yung-Chul O, Kim NS, Park HK, Yum MK,. Use of inhaled iloprost in an infant with bronchopulmonary dysplasia and pulmonary artery hypertension. Korean Circ J 2009; 39: 343-345.